Litigation

Eli Lilly and Company v. Cobalt Laboratories

resolved
Terminated
2011-04-27

Patents at issue (1)

Summary

Cobalt Laboratories was named as a defendant in Lilly's 2008 Cymbalta/duloxetine HCl ANDA litigation involving US 5,023,269. The case was resolved by the April 27, 2011 order/dismissals (docket not confirmed).

Case overview & background

Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Key legal developments & outcome

Major rulings, motions, claim construction, settlements, and the present posture or final disposition.

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Plaintiff representatives

Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Defendant representatives

Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Record id: 5023269-eli-lilly-and-company-v-cobalt-laboratories · edit in Admin